Human type 2 phosphatidic acid phosphohydrolases - Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform

被引:148
|
作者
Roberts, R
Sciorra, VA
Morris, AJ [1 ]
机构
[1] SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Hlth Sci Ctr, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA
关键词
D O I
10.1074/jbc.273.34.22059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphatidic acid (PA), lysophosphatidic acid, ceramide l-phosphate (CIP), and sphingosine l-phosphate (S1P) are lipid mediators generated by phospholipases, sphingomyelinases, and lipid kinases, The major pathway for degradation of these lipids is dephosphorylation catalyzed by members of two classes (types 1 and 2) of phosphohydrolase activities (PAPs), cDNAs encoding two type 2 PAPs, PAP-2a and -2b, have been expressed by transient transfection and shown to catalyze hydrolysis of PA, CIP, and SIP (Kai, M., Wada, I., Imai, S., Sakane, F. and Kanoh, H. (1997) J. Biol. Chem. 272, 24572-24578), We report the cloning and expression of a third type 2 PAP enzyme (288 amino acids, predicted molecular mass of 32.6 kDa), PAP-2c, which exhibits 54 and 43% sequence homology to PAPs 2a and 2b. Expression of HA epitope-tagged PAP-2a, -2b, and 2c in HEK293 cells produced immunoreactive proteins and increased membrane-associated PAP activity. Sf9 insect cells contain very low endogenous PAP activity. Recombinant expression of the three PAP enzymes using baculovirus vectors produces dramatic increases in membrane-associated Mg2+-independent, N-ethylmaleimide-insensitive PAP activity, Expression of PAP-2a but not PAP-2b or -2c resulted in high levels of cell surface PAP activity in intact insect cells. Kinetic analysis of PAP-2a, -2b, and -2c activity against PA, lysophosphatidic acid, C1P, and S1P presented in mixed micelles of Triton X-100 revealed differences in substrate specificity and susceptibility to inhibition by sphingosine, Zn2+, and propranol.
引用
收藏
页码:22059 / 22067
页数:9
相关论文
共 50 条
  • [1] Human type-2 phosphatidic acid phosphohydrolases: Substrate specificity of the type -2a, -2b and -2c enzymes and cell surface activity of the 2a isoform.
    Roberts, R
    Sciorra, VA
    Morris, AJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R678 - R678
  • [2] Cell surface activities of the human type 2b phosphatidic acid phosphatase
    Ishikawa, T
    Kai, M
    Wada, I
    Kanoh, H
    JOURNAL OF BIOCHEMISTRY, 2000, 127 (04): : 645 - 651
  • [3] Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B
    Greenberg, Leslie A.
    PRIMARY CARE, 2024, 51 (03): : 483 - 494
  • [4] Synthesis and metabolism of catecholamines in the brain of α2a, α2b and α2c KO mice
    Moura, E.
    Afonso, J.
    Serrao, M. P.
    Vieira-Coelho, M. A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 24 - 24
  • [5] CHEMOTHERAPY OF NON-SEMINOMATOUS TUMORS IN STAGES 2A, 2B, 2C
    WAGENKNECHT, LV
    MEDENWALDT, B
    JOURNAL D UROLOGIE, 1981, 87 (10) : 679 - 680
  • [6] Molecular modelling of subtypes (α2A, α2B and α2C) of α2-adrenoceptors: A comparative study
    Balogh, Balazs
    Szilagyi, Andras
    Gyires, Klara
    Bylund, David B.
    Matyus, Peter
    NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (06) : 355 - 361
  • [7] Frontal Sinus Surgeries Type 1, 2a, 2b and 3
    Rettinger, G.
    LARYNGO-RHINO-OTOLOGIE, 2021, 100 (04) : 326 - 329
  • [8] Ligand modulation of [35S]GTPγS binding at human α2A, α2B and α2C adrenoceptors
    Audinot, V
    Fabry, N
    Nicolas, JP
    Beauverger, P
    Newman-Tancredi, A
    Millan, MJ
    Try, A
    Bornancin, F
    Canet, E
    Boutin, JA
    CELLULAR SIGNALLING, 2002, 14 (10) : 829 - 837
  • [9] Commentary: 2B or 2A, that is the question
    Hui, Dawn S.
    Lee, Richard
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (01): : E33 - E33
  • [10] GDNF family receptor α 2B (GFRΑ2b) is an inhibitory receptor splice variant that antagonize activities of GFRΑ2A/2C
    Yoong, L. F.
    Too, H. P.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 270 - 270